CY1107399T1 - Μορφη χορηγησης απο του στοματος περιεχουσα προβιοτικα βακτηριδια - Google Patents

Μορφη χορηγησης απο του στοματος περιεχουσα προβιοτικα βακτηριδια

Info

Publication number
CY1107399T1
CY1107399T1 CY20081100430T CY081100430T CY1107399T1 CY 1107399 T1 CY1107399 T1 CY 1107399T1 CY 20081100430 T CY20081100430 T CY 20081100430T CY 081100430 T CY081100430 T CY 081100430T CY 1107399 T1 CY1107399 T1 CY 1107399T1
Authority
CY
Cyprus
Prior art keywords
administration
oral content
oral
content
probiotic
Prior art date
Application number
CY20081100430T
Other languages
English (en)
Inventor
Markus Rudolph
Stefan Henke
Iris Manneck
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34980007&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1107399(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of CY1107399T1 publication Critical patent/CY1107399T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Η εφεύρεση αφορά μία μορφή χορήγησης από του στόματος, η οποία περιέχει τουλάχιστον ένα γένος προβιοτικών μικροοργανισμών, όπου η ίδια και /ή τα προβιοτικά βακτηρίδια είναι εφοδιασμένη/α με μία επικάλυψη, η οποία περιέχει τουλάχιστον δύο αιθέρες κυτταρίνης.
CY20081100430T 2004-05-28 2008-04-17 Μορφη χορηγησης απο του στοματος περιεχουσα προβιοτικα βακτηριδια CY1107399T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004026706A DE102004026706A1 (de) 2004-05-28 2004-05-28 Orale Darreichungsform enthaltend probiotische Bakterien
EP05746643A EP1753440B1 (de) 2004-05-28 2005-05-04 Orale darreichungsform enthaltend probiotische bakterien

Publications (1)

Publication Number Publication Date
CY1107399T1 true CY1107399T1 (el) 2012-12-19

Family

ID=34980007

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20081100430T CY1107399T1 (el) 2004-05-28 2008-04-17 Μορφη χορηγησης απο του στοματος περιεχουσα προβιοτικα βακτηριδια

Country Status (20)

Country Link
US (2) US20090162322A1 (el)
EP (1) EP1753440B1 (el)
JP (1) JP5070043B2 (el)
KR (1) KR101289413B1 (el)
CN (1) CN1956724B (el)
AT (1) ATE386534T1 (el)
AU (1) AU2005249187B2 (el)
BR (1) BRPI0511615B8 (el)
CA (1) CA2568171C (el)
CY (1) CY1107399T1 (el)
DE (2) DE102004026706A1 (el)
DK (1) DK1753440T3 (el)
ES (1) ES2299034T3 (el)
MX (1) MXPA06013686A (el)
PL (1) PL1753440T3 (el)
PT (1) PT1753440E (el)
RU (1) RU2376023C2 (el)
SI (1) SI1753440T1 (el)
WO (1) WO2005117921A1 (el)
ZA (1) ZA200610768B (el)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2368344T3 (es) * 2005-05-18 2011-11-16 Dsm Ip Assets B.V. Composiciones para aplicación parenteral de microorganismos.
US9084434B2 (en) 2006-09-27 2015-07-21 Little Calumet Holdings Llc Probiotic oral dosage forms
BRPI0719787A2 (pt) * 2006-10-02 2014-11-25 Danisco Probióticos para uso na redução da incidência e duração de enfermidade
WO2010114864A1 (en) * 2009-04-01 2010-10-07 Little Calumet Holdings, Llc Probiotic oral dosage forms
US8834853B2 (en) 2009-08-14 2014-09-16 DuPont Nutrition BioScience ApS Coated dehydrated microorganisms with enhanced stability and viability
JP5836928B2 (ja) 2010-03-12 2015-12-24 カルピス株式会社 大腸におけるビフィズス菌の増加及び減少抑制剤
CA2831345C (en) 2011-05-06 2022-05-03 Organobalance Medical Ag Lactic acid bacterial strains that coaggregate with staphylococcus aureus, and compositions and uses of the strains
ES2660775T3 (es) 2011-05-16 2018-03-26 Belano Medical Ag Nuevas bacterias del ácido láctico y composiciones que las contienen contra los resfriados bacterianos
ITMI20120131A1 (it) * 2012-02-01 2013-08-02 Probiotical Spa Batteri probiotici microincapsulati multistrato, loro produzione ed uso
CN104302278B (zh) 2012-03-29 2018-08-21 塞拉拜姆有限责任公司 在回肠和阑尾上有活性的胃肠位点特异性口服接种疫苗制剂
RU2491079C1 (ru) * 2012-07-13 2013-08-27 Федеральное бюджетное учреждение науки Институт элементоорганических соединений им. А.Н. Несмеянова Российской академии наук (ИНЭОС РАН) Комплексный пробиотический препарат и способ его получения
TWI481409B (zh) * 2013-01-10 2015-04-21 Conmed Pharmaceutical & Bio Medical Corp 一種使用益生菌製備用於清除尿毒素之組合物的用途
CN105120847B (zh) 2013-03-14 2018-12-28 塞拉拜姆有限责任公司 益生生物和/或治疗剂的靶向胃肠道递送
US10849940B2 (en) * 2013-06-10 2020-12-01 Brock M. Lundberg Prebiotics of highly refined cellulose
KR101470995B1 (ko) * 2013-08-30 2014-12-09 주식회사 바이오리쏘스 프로피온산 생산능을 갖는 미생물 및 그를 포함하는 조사료 조성물
AU2015284425B2 (en) 2014-07-01 2021-04-01 Probi USA, Inc. Bi-layer dual release probiotic tablets
ES2575828B1 (es) * 2014-12-31 2017-07-07 Universidad De León Empleo de probióticos en el incremento de la fertilidad masculina
US10339273B2 (en) 2015-11-18 2019-07-02 Warsaw Orthopedic, Inc. Systems and methods for pre-operative procedure determination and outcome predicting
CN111870617B (zh) * 2019-11-04 2022-06-10 深圳碳云智能数字生命健康管理有限公司 肠道益生菌补剂配方的确定方法、装置、存储介质及处理器
CN111110703B (zh) * 2020-01-13 2020-12-01 华中农业大学 动物双歧杆菌及其制备的复合菌制剂在制备治疗或预防禽流感病毒感染的药物中的应用
CN114917259B (zh) * 2022-02-15 2023-10-13 中国科学院上海硅酸盐研究所 一种二维氢硅烯-微生物复合材料及其制备方法和应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58157726A (ja) * 1982-03-11 1983-09-19 Shin Etsu Chem Co Ltd 固形薬剤用腸溶性コ−テイング剤組成物
JPH024016A (ja) * 1988-06-20 1990-01-09 Fujitsu Ltd 半導体集積回路
JPH0441434A (ja) * 1990-06-07 1992-02-12 Asahi Breweries Ltd 腸溶性コーティングを施した乳酸菌錠剤
US5160742A (en) * 1991-12-31 1992-11-03 Abbott Laboratories System for delivering an active substance for sustained release
IT1265092B1 (it) * 1993-05-31 1996-10-30 Giuliani Spa Preparato per uso come integratore alimentare, o dietetico,a rilascio mirato nel colon
US5482718A (en) * 1994-03-23 1996-01-09 Hoffmann-La Roche Inc. Colon-targeted delivery system
US6168806B1 (en) * 1999-03-05 2001-01-02 Fang-Yu Lee Orally administrable nifedipine pellet and process for the preparation thereof
EP1072258A1 (de) * 1999-07-28 2001-01-31 Greither, Peter Eine Kapsel für die Freisetzung von Bakterien, enthaltend ein Bakterienlyophilisat und ein Verfahren zu ihrer Herstellung
DE19937361A1 (de) * 1999-08-12 2001-02-22 Merck Patent Gmbh Orale Darreichungsform
CN1156271C (zh) * 2000-04-29 2004-07-07 中国科学技术大学 一种固体药剂用高分子包衣粉及其制备方法
US6749867B2 (en) * 2000-11-29 2004-06-15 Joseph R. Robinson Delivery system for omeprazole and its salts
US20020160048A1 (en) * 2001-02-15 2002-10-31 Karoline Bechtold-Peters Medical formulation containing a muscarinic agonist
BR0207948A (pt) * 2001-03-09 2004-07-27 Produits Nestel S A Soc D Composição que melhora os déficits fisiológicos relacionados com a idade e que aumenta a longevidade
US7101565B2 (en) * 2002-02-05 2006-09-05 Corpak Medsystems, Inc. Probiotic/prebiotic composition and delivery method
US20040001817A1 (en) * 2002-05-14 2004-01-01 Giampapa Vincent C. Anti-aging nutritional supplement
US20050266069A1 (en) * 2002-09-06 2005-12-01 Simmons Donald L Stable probiotic microsphere compositions and their methods of preparation

Also Published As

Publication number Publication date
EP1753440B1 (de) 2008-02-20
SI1753440T1 (sl) 2008-08-31
MXPA06013686A (es) 2007-02-13
PT1753440E (pt) 2008-05-28
ATE386534T1 (de) 2008-03-15
BRPI0511615A (pt) 2008-01-02
ES2299034T3 (es) 2008-05-16
AU2005249187A1 (en) 2005-12-15
ZA200610768B (en) 2008-07-30
US20090162322A1 (en) 2009-06-25
CN1956724A (zh) 2007-05-02
BRPI0511615B1 (pt) 2018-01-23
JP5070043B2 (ja) 2012-11-07
CA2568171C (en) 2013-09-17
CN1956724B (zh) 2013-08-28
KR20070024539A (ko) 2007-03-02
RU2006145056A (ru) 2008-07-10
US20190110997A1 (en) 2019-04-18
EP1753440A1 (de) 2007-02-21
PL1753440T3 (pl) 2008-05-30
DE502005002929D1 (de) 2008-04-03
KR101289413B1 (ko) 2013-08-07
BRPI0511615B8 (pt) 2021-05-25
WO2005117921A1 (de) 2005-12-15
JP2008500294A (ja) 2008-01-10
DE102004026706A1 (de) 2005-12-15
CA2568171A1 (en) 2005-12-15
AU2005249187B2 (en) 2011-03-17
RU2376023C2 (ru) 2009-12-20
DK1753440T3 (da) 2008-06-02

Similar Documents

Publication Publication Date Title
CY1107399T1 (el) Μορφη χορηγησης απο του στοματος περιεχουσα προβιοτικα βακτηριδια
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
MA32876B1 (fr) Anticorps dirigés contre l'angiopoïétine 2 humaine
TW200700009A (en) Active compound combinations having insecticidal and acaricidal properties
DK2094107T3 (da) Mykotoksin-reducerende sammensætning
WO2008118749A3 (en) Preventing and reducing biofilm formation and planktonic proliferation
EA200702430A1 (ru) Модифицированные микроорганизмы с инактивированным геном лактатдегидрогеназы
ATE407215T1 (de) Enzymatische demethylierung von flavonoiden
TNSN08284A1 (en) Masking the taste of powders
WO2008064345A3 (en) Microorganism killing compounds
EA201001024A1 (ru) Обработка растений банана и картофеля с помощью новой противогрибковой композиции
MX2010001849A (es) Depsipeptidos ciclicos.
TW200738751A (en) Anti-EphrinB2 antibodies and methods using same
UA97369C2 (ru) Противоопухолевые соединения дигидропиран-2-она и фармацевтическая композиция на их основе
MY148276A (en) Long-term feed- elderly
ATE433459T1 (de) Desoxo-nonadepsipeptide
CL2007001910A1 (es) Compuestos derivados de penem; composicion farmaceutica; y uso en el tratamiento de una infeccion bacteriana.
RS51896B (en) The use of glucose isomerase in the treatment of fructose intolerance
ATE455789T1 (de) Substituierte nonadepsipeptide
AU316238S (en) Lawning applicator for microbiological cultures
WO2010036344A8 (en) Compositions, oral care products and methods of making and using the same
BRPI0817090A2 (pt) Método de cultura e uma espécie bacteriana da família anaplasmataceae, e, composição.
NO20032494D0 (no) Farmasöytisk blanding
TW200613604A (en) Preparation of fabrics having lotus leaf effect and fabrics having lotus leaf effect
FR2907121B1 (fr) Nouveaux derives morphiniques